1. Health Canada: cancer risk with gentian violet products?

   News item 29 June 2019 Pages: 1 - 1

2. RXQ Compounding voluntarily recalls all sterile products

   News item 29 June 2019 Pages: 2 - 2

3. Serious AEs linked with investigational faecal microbiota

   News item 29 June 2019 Pages: 3 - 3

4. Cancer risk evaluated in PsA patients treated with TNFi

   Clinical study 29 June 2019 Pages: 4 - 4

5. Cardiovascular AEs more common with carfilzomib than bortezomib

   Clinical study 29 June 2019 Pages: 5 - 5

6. Dolutegravir exposure: no increase in congenital abnormalities

   Clinical study 29 June 2019 Pages: 6 - 6

7. Inactivated versus live influenza vaccines in children with asthma

   Clinical study 29 June 2019 Pages: 7 - 7

8. IV infusion practices, errors compared in US and England

   Clinical study 29 June 2019 Pages: 8 - 8

9. Live attenuated vaccines safe in paediatric rheumatic diseases?

   Clinical study 29 June 2019 Pages: 9 - 9

10. No evidence of harm with long-term pantoprazole?

    Clinical study 29 June 2019 Pages: 10 - 10

11. Opioid-related AEs highly prevalent with short-term use

    Clinical study 29 June 2019 Pages: 11 - 11

12. Serious adverse GI events with sodium polystyrene sulfonate

    Clinical study 29 June 2019 Pages: 12 - 12

13. Abacavir

    Case report 29 June 2019 Pages: 13 - 13

14. Adalimumab

    Case report 29 June 2019 Pages: 14 - 14

15. Adalimumab

    Case report 29 June 2019 Pages: 15 - 15

16. Adenovirus-vaccine/listeria-monocytogenes-vaccine

    Case report 29 June 2019 Pages: 16 - 16

17. Aflibercept

    Case report 29 June 2019 Pages: 17 - 17

18. Alemtuzumab

    Case report 29 June 2019 Pages: 18 - 18

19. Alemtuzumab

    Case report 29 June 2019 Pages: 19 - 19

20. Aminocaproic acid/antineoplastics/vitamin K

    Case report 29 June 2019 Pages: 20 - 20

21. Amiodarone

    Case report 29 June 2019 Pages: 21 - 21

22. Amiodarone

    Case report 29 June 2019 Pages: 22 - 22

23. Amiodarone

    Case report 29 June 2019 Pages: 23 - 23

24. Amiodarone

    Case report 29 June 2019 Pages: 24 - 24

25. Amiodarone

    Case report 29 June 2019 Pages: 25 - 25

26. Amiodarone/flecainide

    Case report 29 June 2019 Pages: 26 - 26

27. Anakinra

    Case report 29 June 2019 Pages: 27 - 27

28. Anakinra

    Case report 29 June 2019 Pages: 28 - 28

29. Anakinra/dexamethasone

    Case report 29 June 2019 Pages: 29 - 29

30. Antibacterials/amphotericin-B/ganciclovir

    Case report 29 June 2019 Pages: 30 - 30

31. Antifungals/cytokines

    Case report 29 June 2019 Pages: 31 - 31

32. Antineoplastics

    Case report 29 June 2019 Pages: 32 - 32

33. Antineoplastics

    Case report 29 June 2019 Pages: 33 - 33

34. Antineoplastics

    Case report 29 June 2019 Pages: 34 - 34

35. Antineoplastics/bisphosphonates

    Case report 29 June 2019 Pages: 35 - 35

36. Antineoplastics/folinic acid

    Case report 29 June 2019 Pages: 36 - 36

37. Antiretrovirals

    Case report 29 June 2019 Pages: 37 - 37

38. Antiretrovirals

    Case report 29 June 2019 Pages: 38 - 38

39. Antiretrovirals

    Case report 29 June 2019 Pages: 39 - 39

40. Antithrombin-III/thrombomodulin-α

    Case report 29 June 2019 Pages: 40 - 40

41. Antithymocyte globulin/busulfan/cyclophosphamide

    Case report 29 June 2019 Pages: 41 - 41

42. Antituberculars

    Case report 29 June 2019 Pages: 42 - 42

43. Antivirals

    Case report 29 June 2019 Pages: 43 - 43

44. Argatroban/heparin

    Case report 29 June 2019 Pages: 44 - 44

45. Aripiprazole

    Case report 29 June 2019 Pages: 45 - 45

46. Aripiprazole/valbenazine

    Case report 29 June 2019 Pages: 46 - 46

47. Asparaginase

    Case report 29 June 2019 Pages: 47 - 47

48. Aspirin

    Case report 29 June 2019 Pages: 48 - 48

49. Axalimogene filolisbac

    Case report 29 June 2019 Pages: 49 - 49

50. Azathioprine

    Case report 29 June 2019 Pages: 50 - 50